
Healthcare · BSE
Hamps Bio Limited, incorporated in 2007, is engaged in marketing and distributing pharmaceutical products under the “Hamps” brand and freeze-dried and frozen FMCG items under the “FzyEzy” brand. Its pharmaceutical portfolio includes tablets, syrups, capsules, injectables, and powders, distributed across eight Indian states and union territories through 50+ distributors and online platforms such as Amazon, Flipkart, and Jio Mart. The company’s FMCG division offers freeze-dried and frozen products like strawberry, mango, and beet powders for both B2B and B2C markets, including contract manufacturing. With a portfolio of 180+ products across both verticals, Hamps Bio serves domestic and international markets and employed 78 people as of October 31, 2024.
Price Band
₹51
Issue Size
₹6.22 Cr
Lot Size
2000 shares
GMP
+117.7%
Est. Listing
₹111
at current GMP
Subscribed
1050.21x
overall
Open
13 Dec 2024
Close
17 Dec 2024
Allotment
18 Dec 2024
Refund
19 Dec 2024
Demat Credit
20 Dec 2024
Listing
20 Dec 2024
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹51
Band: ₹51
Estimated Listing Price
₹111
Upper price + GMP
Lot Size
2000 shares
Min investment ₹1,02,000
Estimated Profit / Lot
₹1,20,000
2000 × ₹60
Grey Market Premium trend
+₹60
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹60 | 117.7% | ₹111 |
| 30 Oct 2026 | +₹60 | 117.7% | ₹111 |
| 29 Oct 2026 | +₹54 | 105.9% | ₹105 |
GMP is unofficial market data. Not a guarantee of listing performance.
Hamps Bio Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹6.22 Crores. The shares are offered at a price band of ₹51 to ₹51 per equity share on BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2024-12-17, the basis of allotment is scheduled to be finalized on 2024-12-18. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
The latest grey market premium for Hamps Bio Limited IPO is ₹60, which indicates an expected listing price of ₹111.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.